NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ:CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that it will present at the at the upcoming Noble Financial Fourth Annual Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, NV. Drew Fromkin, President and Chief Executive Officer will discuss the Company’s business strategy and historical financial performance at 1:30 p.m. Pacific Time on Monday, August 18th.
